These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30234130)

  • 1. Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.
    Pandya NR; Alphonso N; Tu Q; Venugopal P; Schlapbach LJ
    Front Cardiovasc Med; 2018; 5():121. PubMed ID: 30234130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.
    Carrel T; Englberger L; Mohacsi P; Neidhart P; Schmidli J
    J Card Surg; 2000; 15(5):347-53. PubMed ID: 11599828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
    Hollmann C; Fernandes NL; Biccard BM
    Anesth Analg; 2018 Sep; 127(3):678-687. PubMed ID: 29381513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment and outcomes of vasoplegia after cardiac surgery.
    Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
    Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
    White CM; Kluger J; Lertsburapa K; Faheem O; Coleman CI
    Eur J Cardiothorac Surg; 2007 May; 31(5):817-20. PubMed ID: 17350856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antihypertensive therapy in new users of angiotensin II-receptor blockers.
    Young CH; Zhang K; Poret AW
    Am J Health Syst Pharm; 2005 Nov; 62(22):2381-5. PubMed ID: 16278329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
    Arevalo VN; Bullerwell ML
    AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
    Coleman CI; Makanji S; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoplegic syndrome: An update on perioperative considerations.
    Liu H; Yu L; Yang L; Green MS
    J Clin Anesth; 2017 Aug; 40():63-71. PubMed ID: 28625450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies.
    Barnes TJ; Hockstein MA; Jabaley CS
    SAGE Open Med; 2020; 8():2050312120935466. PubMed ID: 32647575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S; Roughead EE; Bartlett LE
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response.
    Kerbaul F; Collart F; Giorgi R; Ibrahim Z; Guillen JC; Gil JM; Saadjian A; Mouly-Bandini A; Habib G; Gouin F; Guieu R
    Crit Care Med; 2006 Mar; 34(3):640-5. PubMed ID: 16505647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
    Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation.
    Chan JL; Kobashigawa JA; Aintablian TL; Dimbil SJ; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Ann Thorac Surg; 2018 Mar; 105(3):770-777. PubMed ID: 29289367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.